OUTLOOK 2019 AS THE TIDE GOES OUT...

As the tide of easy monetary policy slowly goes out, global markets face another challening year. Yet 2019 will be very different from 2018, as the US economy is set to fall off its pedestal; the Fed will pause this summer, if not before. The great regional divergence of 2018 will thus end, and with it the impressive USD rally. This should bring selective relief to Emerging Markets, assuming the world economic landing continues to be soft.

Highlights:

  • As the tide of easy monetary policy slowly goes out, global markets face another challenging year.
  • Yet 2019 will be very different from 2018, as the US economy is set to fall off its pedestal; the Fed will pause this summer, if not before. The great regional divergence of 2018 will thus end, and with it the impressive USD rally. This should bring selective relief to Emerging Markets, assuming the world economic landing continues to be soft.
  • As the US economy soon celebrates its longest cycle ever, fears of a downturn will not vanish. This creates a toxic asymmetry for risky assets: limited upside, larger downside.
  • Yet there is too much pessimism about a global – and more particularly European – hard landing just now: the late 2018 capitulation has created oversold conditions. We will start with a prudent overweight in equities and credit. Qual-ity will be of the essence in 2019, like in all late cycles. We retain a long cash position, as well as a short in EUR Go-vies. We go nimble on duration, and see better value in playing that through derivatives.

Download the full publication below

OUTLOOK 2019 AS THE TIDE GOES OUT…

RELATED INSIGHTS

CHINA’S RECOVERY CONTINUED BUT A BIT SOFTER THAN EXPECTED
China's economic recovery continued in Q3 2020, although a bit softer than expected. Real GDP growth rose to 4.9% yoy, slightly below the Reuters consensus expectation of 5.2% yoy, but still a substantial upturn from the 3.2% yoy in Q2. On a quarterly base, growth dynamics softened to 2.7% qoq, after 11.7% qoq and -10% qoq in the two previous quarters.
Citywire video-interview with Peter Marber
Watch Peter Marber, fund manager of this global, non-directional, long/short approach to Emerging Markets debt, in a video-interview by Citywire.
COVID-19 FACTS & FIGURES
According to the IMF’s Managing Director, strong international cooperation on coronavirus vaccine could speed up the world economic recovery and add $9 trillion to global income by 2025. A WHO trial found that Remdesivir, Hydroxychloroquine, Lopinavir and Interferon have little or no effect on hospitalized Covid-19 patients. Gilead Sciences has questioned the findings of the WHO study saying data appeared inconsistent.